What is the appropriate emergency department management for a patient with rheumatic heart disease who has been lost to follow‑up?

Emergency Department Management for RHD Patients Lost to Follow-Up

Immediately restart secondary prophylaxis with penicillin G benzathine 1.2 million units intramuscularly and arrange urgent cardiology follow-up within 1-2 weeks, as recurrent rheumatic fever worsens valvular disease even when streptococcal infections are asymptomatic. 1, 2

Critical Initial Actions

1. Restart Secondary Prophylaxis Immediately

The most important ED intervention is reinitiating antibiotic prophylaxis before discharge, as recurrent rheumatic fever can occur without symptomatic streptococcal infection and leads to progressive valve damage 1.

Preferred regimen:

• Penicillin G benzathine 1.2 million units IM every 4 weeks 1, 2
• Consider every 3 weeks if high-risk (severe valve disease, high streptococcal exposure) 1, 2

Alternative regimens (if IM not feasible):

• Penicillin V potassium 250 mg orally twice daily 2
• Sulfadiazine 1 g orally once daily 2
• Macrolide/azalide (if penicillin allergic) - avoid with CYP3A inhibitors 1, 2

2. Assess Current Cardiac Status

Evaluate for acute decompensation or progression:

• Symptoms: New or worsening dyspnea, chest pain, syncope, palpitations, edema
• Physical exam: Heart murmurs (mitral regurgitation most common), signs of heart failure (rales, elevated JVP, peripheral edema), arrhythmias
• ECG: Assess for atrial fibrillation, heart block, or ischemic changes
• Chest X-ray: Cardiomegaly, pulmonary edema, valve calcification

If symptomatic or signs of decompensation:

• Obtain urgent echocardiography (can be done in ED if available) 3
• Initiate guideline-directed medical therapy for heart failure if indicated: diuretics, ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists 1, 2
• Avoid abrupt blood pressure lowering in stenotic lesions 2
• Consider admission for severe symptoms, new arrhythmias, or acute heart failure

3. Determine Prophylaxis Duration

Calculate required duration based on disease severity 1, 2:

• RHD with residual valve disease: 10 years from last attack OR until age 40 (whichever is longer)
• RHD with carditis but no residual disease: 10 years OR until age 21 (whichever is longer)
• RF without carditis: 5 years OR until age 21 (whichever is longer)

Critical caveat: Lifelong prophylaxis may be needed if high streptococcal exposure risk, and prophylaxis is required even after valve replacement 1, 2

4. Arrange Structured Follow-Up

Before ED discharge, ensure:

• Cardiology appointment within 1-2 weeks 3
• Primary care follow-up within 1 week to ensure prophylaxis adherence
• Patient education on importance of continuous prophylaxis (recurrence risk is high without it) 3, 4
• Written discharge instructions with prophylaxis schedule
• Social work consultation if adherence barriers exist

Common Pitfalls to Avoid

1. Delaying prophylaxis restart: Don't wait for cardiology follow-up - give first dose in ED 1, 3
2. Underestimating asymptomatic patients: Valve damage progresses even without symptoms; all patients need prophylaxis 1, 4
3. Inadequate duration: Many patients stop prophylaxis too early; recalculate based on current guidelines 1, 2
4. Missing infective endocarditis prophylaxis: If patient has prosthetic valves or previous IE, dental procedure prophylaxis is also indicated 2
5. Assuming compliance will improve: Address barriers (pain management for IM injections, transportation, cost) before discharge 5

Disposition Decision

Admit if:

• Acute heart failure or hemodynamic instability
• New-onset atrial fibrillation requiring rate control
• Severe valve dysfunction with symptoms
• Suspected acute rheumatic fever recurrence (fever, arthritis, carditis) 3

Safe for discharge if:

• Hemodynamically stable
• No acute cardiac decompensation
• Reliable follow-up arranged
• First prophylaxis dose administered
• Patient understands importance of adherence